Case study: Boyds supports the acquisition of UK-based oncology drug developer with scientific due diligence

Case study: Large company investments – Boyds supports the acquisition of UK-based oncology drug developer Background: The client was a large Asian-headquartered biopharmaceutical company, looking to grow through the purchase of multiple clinical and pre-clinical acquisitions. The target company with whom they wanted to engage with was a UK-based biotech company with assets in both […]

Case study: Assessment of novel vaccine technology triggers further investment

Case study: Assessment of novel vaccine technology triggers further investment Background: The client was a large multi-national fund, who has part ownership of a small biotech with a novel platform technology. The target company with whom they wanted to engage with was a European-based biotech company who were developing a novel technology platform to facilitate the […]